GlassScriptPhysician profile
Charles Glenn Ison
NPI 1144298993
$858.15
in general payments reported to CMS, 2019-2025
16 companies · $119 in 2025
The $119 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $82.64 · 2022: $149 · 2023: $193 · 2024: $41.04 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $131.16 | 2019-2023 | Vaxneuvance, Gardasil 9, Vaxelis |
| Abbott Laboratories | $118.64 | 2025 | Id Now Strep A 2 |
| Glaxosmithkline, LLC. | $94.52 | 2019-2024 | Bexsero |
| Tris Pharma INC | $77.84 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $76.12 | 2019-2023 | Jornay Pm |
| Corium, LLC | $58.66 | 2023-2024 | Azstarys |
| Supernus Pharmaceuticals, INC. | $56.57 | 2022-2023 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $48.27 | 2019 | |
| Genentech USA, INC. | $48.14 | 2019-2020 | |
| Pfizer INC. | $40.89 | 2019-2020 | |
| Shire North American Group INC | $33.19 | 2019 | |
| Avion Pharmaceuticals | $20.78 | 2023 | Methylphenidate Hydrochloride |
| Neos Therapeutics, LP | $14.21 | 2020 | |
| Quidel Corporation | $14.05 | 2019 | |
| Sobi, INC | $13.16 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Ison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.